Cara Therapeutics, Inc.
(NASDAQ CM: CARA)
Rigrodsky Law, P.A. is investigating Cara Therapeutics, Inc. (“Cara”) regarding possible breaches of fiduciary duties and other violations of law related to Cara’s agreement to merge with Tvardi Therapeutics, Inc.